| Literature DB >> 17164523 |
Abstract
Isothermal titration calorimetry (ITC) provides highly complementary data to high-resolution structural detail. An overview of the methodology of the technique is provided. Ultimately, the correlation of the thermodynamic parameters determined by ITC with structural perturbation observed on going from the free to the bound state should be possible at an atomic level. Currently, thermodynamic data provide some insight as to potential changes occurring on complex formation. Here, this is demonstrated in the context of in vitro quantification of intracellular tyrosine kinase-mediated signal transduction and the issue of specificity of the important interactions. The apparent lack of specificity in the interactions of domains of proteins involved in early signalling from membrane-bound receptors is demonstrated using data from ITC.Entities:
Mesh:
Substances:
Year: 2006 PMID: 17164523 PMCID: PMC2483503 DOI: 10.1107/S0907444906046373
Source DB: PubMed Journal: Acta Crystallogr D Biol Crystallogr ISSN: 0907-4449
Figure 1(a) Schematic of an isothermal titration calorimeter. (b) Raw data output and (c) integrated data. (a) shows the sample cell and the reference cell in an isothermal jacket. The syringe is inserted in the sample cell and a series of injections are made. The injection of one component into the other results in an exothermic heat effect. After each injection, once the interaction is complete the power returns to an equilibrium value (b). The concentration regime between the two components is set up such that after a series of injections the binding sites available in the sample cell are gradually saturated. The profile of the binding isotherm (c) is fitted to obtain the thermodynamic parameters (see text).
Figure 2Surface representation of the binding site of the Src SH2 domain showing the ‘two-pinned plug’ mode of binding. The colours are used to emphasize depth of pocket only.
Binding of tyrosyl phosphopeptides to the Src SH2 domain at 298 K
| Peptide | Δ | Δ | Reference | ||
|---|---|---|---|---|---|
| Peptides based on ‘specific’ sequence | |||||
| KGGQpYEEIPIP | 0.55 | −35.4 | 0.5 | −36.0 | |
| KGGQpYEEIPIP | 0.77 | −33.4 | 1.7 | −35.1 | |
| EPQpYEEIPIYL | 0.09 | −38.7 | 1.4 | −40.1 | |
| PQpYEEIPI | 0.18 | −32.3 | 6.3 | −38.6 | |
| PQpYEEIPI | 0.25 | −31.5 | 6.3 | −37.8 | |
| PQpYEEIPI | 0.27 | −31.5 | 6.3 | −37.8 | |
| PQpYEEIPI | 0.2 | −27.3 | 10.9 | −38.2 | |
| pY | 175 | 3.3 | 24.1 | −21.4 | |
| Peptides with substitution in pY + 1 position of ‘specific’ sequence | |||||
| PQpYQEIPI | 0.47 | −31.9 | 4.2 | −36.1 | |
| PQpYDEIPI | 0.18 | −37.4 | 1.3 | −38.6 | |
| PQpYAEIPI | 0.34 | −32.3 | 4.2 | −36.5 | |
| PQpYGEIPI | 6.25 | −20.2 | 9.7 | −29.8 | |
| PQpYAEIPI | 0.35 | −32.3 | 4.2 | −36.5 | |
| Peptides with substitution in pY + 2 position of ‘specific’ sequence | |||||
| PQpYEYIPI | 0.66 | −26.8 | 8.4 | −35.2 | |
| PQpYEQIPI | 0.53 | −31.9 | 4.2 | −36.1 | |
| PQpYEDIPI | 0.42 | −26.0 | 10.5 | −36.5 | |
| PQpYEAIPI | 1.04 | −26.5 | 8.0 | −34.4 | |
| PQpYEAIPI | 1.0 | −26.46 | 7.98 | −34.44 | |
| PQpYEGIPI | 1.96 | −25.2 | 7.6 | −32.8 | |
| Peptides with substitution in pY + 3 position of ‘specific’ sequence | |||||
| EPQpYEEVPIYL | 0.16 | −28.6 | 10.2 | −38.8 | |
| EPQpYEEEPIYL | 0.21 | −32.7 | 5.4 | −38.1 | |
| EPQpYEEWPIYL | 0.31 | −32.2 | 4.9 | −37.1 | |
| EPQpYEEDPIYL | 0.38 | −27.5 | 9.1 | −36.6 | |
| PQpYEELPI | 0.43 | −23.5 | 13.0 | −36.5 | |
| PQpYEEVPI | 0.46 | −22.7 | 13.9 | −36.5 | |
| PQpYEEAPI | 1.75 | −21.4 | 11.3 | −32.7 | |
| PQpYEEGPI | 0.39 | −15.1 | 16.0 | −31.1 | |
| Completely randomized sequences | |||||
| PQpYQPGEN | 29.4 | −19.3 | 6.7 | −26.0 | |
| EPQpYQPGEN | 14.3 | −25.7 | 2.0 | −27.7 | |
References for the ITC data: a, Ladbury et al. (1995 ▶); b, Chung et al. (1998 ▶); c, Bradshaw & Waksman (1999 ▶); d, Lubman & Waksman (2003 ▶); e, Lubman & Waksman (2002 ▶); f, Bradshaw et al. (1998 ▶); g, Bradshaw et al. (1999 ▶); h, Henriques & Ladbury (2001 ▶).
Binding of peptides to the SH2 and SH3 domains of Fyn at 298 K
| Peptide | Δ | Δ | ||
|---|---|---|---|---|
| pYEEI | 2.5 | −45 | −13 | −32 |
| PXXP | 62.0 | −68 | −43 | −25 |
| FAK peptide | 0.19 | −132 | −94 | −38 |
Figure 3Ribbon diagram representation of the apo-ZAP70 SH2 domains and inter-SH2 domain linker (based on Folmer et al., 2002 ▶). The N-terminal SH2 domain is shown in green and the C-terminal SH2 domain is shown in red. These SH2 domains have to come together to form the binding site for the ITAM bisphosphorylated peptide (see Hatada et al., 1995 ▶).
Binding of peptides to the SH2 domain of ZAP70 at 298 K
| Peptide | Δ | Δ | ||
|---|---|---|---|---|
| N-terminal pY peptide | 142 | −48 | −26 | −22 |
| C-terminal pY peptide | ∼333 | −47 | −27 | −20 |
| Bisphosphopeptide | 0.032 | −59 | −16 | −43 |